Provide your contact details to the exhibitor. Optionally, you may also add a personal message.
Your name, phone number, and e-mail address are subject to the submission of personal data. Messe Düsseldorf GmbH expressly points out that for a data transmission into third countries, for which no adequacy decision of the EU-commission is on hand certifying an adequate level of protection of personal data, it is not ensured that there are appropriate safeguards for the protection of personal data on hand.
Please log in
You must be logged in to send the contact request.
An error has occurred
Please check your internet connection or try again later.
Message has been sent
Your message to the exhibitor was sent successfully.
Product category: Other medical information systems / software
The TrakCel Solution
Personalized cell and gene therapy software
As more personalized therapies are approved, and markets expand globally, commercial success will be dependent on safe and reliable delivery to healthcare providers at scale. This requires robust supply chain management, efficient utilization of resources and regulatory compliance without increasing workload or complexity for end users. We developed TrakCel to address this need.
There is a patient at the end of everything we do. TrakCel was established in 2012 as a joint enterprise between AwenID, a technology company spun out from Swansea University, and Biotec Services International, a specialist provider of ultra-low temperature-controlled supply chain management services to the biotechnology industry. The Biotec team had early exposure to the challenges of managing complex supply chains associated with cell and gene therapies. They saw that for these therapies to succeed at scale, robust supply chain management at an individual therapy level was essential. Around this time, Biotecs management met with Dr Akshay Peer who was seeking life sciences applications for AwenIDs patented tracking technology platform. TrakCel was born as a result of these discussions.
TrakCels vision was to use the expertise of their founders to create a technology-driven, collection-to-administration supply chain management platform for the orchestration and efficient management of cell and gene therapies at clinical trial and commercial scale.